Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) E10: ¥0.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600513 Jiangsu Lianhuan Pharmaceutical Co Ltd SHSE:600513
65 GF Score
Price ¥15.42
GF Value ¥13.72
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Jiangsu Lianhuan Pharmaceutical Co E10?

Jiangsu Lianhuan Pharmaceutical Co SHSE:600513 -6.94% 65 E10 is ¥0.28 as of Mar. 2026. GuruFocus rates SHSE:600513 with a GF Score™ of 65/100 and a GF Value™ of ¥13.72 (Modestly Overvalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jiangsu Lianhuan Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Jiangsu Lianhuan Pharmaceutical Co's average E10 Growth Rate was -17.60% per year. During the past 3 years, the average E10 Growth Rate was -1.20% per year. During the past 5 years, the average E10 Growth Rate was 5.30% per year. During the past 10 years, the average E10 Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Jiangsu Lianhuan Pharmaceutical Co was 18.60% per year. The lowest was -1.20% per year. And the median was 15.25% per year.

As of today (2026-07-24), Jiangsu Lianhuan Pharmaceutical Co's current stock price is ¥15.42. Jiangsu Lianhuan Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥0.28. Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio of today is 55.07.

During the past 13 years, the highest Shiller PE Ratio of Jiangsu Lianhuan Pharmaceutical Co was 107.60. The lowest was 23.26. And the median was 38.87.


Jiangsu Lianhuan Pharmaceutical Co  (SHSE:600513) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jiangsu Lianhuan Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=15.42/0.28
=55.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Jiangsu Lianhuan Pharmaceutical Co was 107.60. The lowest was 23.26. And the median was 38.87.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Jiangsu Lianhuan Pharmaceutical Co E10 Related Terms


Jiangsu Lianhuan Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Lianhuan Pharmaceutical Co E10 Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.29 0.32 0.33 0.28

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.31 0.31 0.28 0.28

SHSE:600513 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Lianhuan Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:600513
65GF Score
Jiangsu Lianhuan Pharmaceutical Co Ltd SHSE:600513
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Lianhuan Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jiangsu Lianhuan Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.02/116.3033*116.3033
=0.020

Current CPI (Mar. 2026) = 116.3033.

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.054 101.400 0.062
201609 0.060 102.400 0.068
201612 0.059 102.600 0.067
201703 0.050 103.200 0.056
201706 0.070 103.100 0.079
201709 0.050 104.100 0.056
201712 0.070 104.500 0.078
201803 0.060 105.300 0.066
201806 0.080 104.900 0.089
201809 0.060 106.600 0.065
201812 0.059 106.500 0.064
201903 0.060 107.700 0.065
201906 0.080 107.700 0.086
201909 0.070 109.800 0.074
201912 0.060 111.200 0.063
202003 0.070 112.300 0.072
202006 0.090 110.400 0.095
202009 0.120 111.700 0.125
202012 0.080 111.500 0.083
202103 0.090 112.662 0.093
202106 0.100 111.769 0.104
202109 0.110 112.215 0.114
202112 0.110 113.108 0.113
202203 0.110 114.335 0.112
202206 0.120 114.558 0.122
202209 0.117 115.339 0.118
202212 0.140 115.116 0.141
202303 0.110 115.116 0.111
202306 0.100 114.558 0.102
202309 0.100 115.339 0.101
202312 0.160 114.781 0.162
202403 0.110 115.227 0.111
202406 0.110 114.781 0.111
202409 0.100 115.785 0.100
202412 -0.030 114.893 -0.030
202503 0.080 115.116 0.081
202506 -0.220 114.907 -0.223
202509 0.020 115.471 0.020
202512 -0.220 115.832 -0.221
202603 0.020 116.303 0.020

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.28 mean?
Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) has a E10 of ¥0.28 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jiangsu Lianhuan Pharmaceutical Co and its competitors.
Is Jiangsu Lianhuan Pharmaceutical Co's E10 too high?
Jiangsu Lianhuan Pharmaceutical Co's current E10 is ¥0.28. Overall, Jiangsu Lianhuan Pharmaceutical Co has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Lianhuan Pharmaceutical Co's E10 compare to ZTS and UTHR?
Jiangsu Lianhuan Pharmaceutical Co's E10 of ¥0.28 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jiangsu Lianhuan Pharmaceutical Co and its competitors. Jiangsu Lianhuan Pharmaceutical Co's current E10 is ¥0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Lianhuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥13.72, compared to a current price of ¥15.42 — trading 12.4% above its estimated fair value. The current E10 is ¥0.28. Jiangsu Lianhuan Pharmaceutical Co's overall GF Score™ is 65/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513), the current E10 is ¥0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Lianhuan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥15.42 is trading 12.4% above its estimated GF Value™ of ¥13.72. GuruFocus considers Jiangsu Lianhuan Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SHSE:600513:

  • E10: ¥0.28
  • GF Value™: ¥13.72 vs. price of ¥15.42 (12.4% above fair value)
  • GF Score™: 65/100 with 10 warning signs

No single metric tells the full story. See the SHSE:600513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jiangsu Lianhuan Pharmaceutical Co Business Description

Address No. 9, Jiankang 1st Road, Yangzhou Bio-Health Industry Park, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225127
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs. In the field of pharmaceutical manufacturing, the company's main products include several series such as urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics, etc., covering chemical raw materials and injections, solid preparations and various drug dosage forms, including the national first-class new drug Apelite Tablets (Chuanliu).
65GF Score

Get the complete analysis for SHSE:600513

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.42
Price
¥13.72
GF Value